Retatrutide vs CagriSema: Comparing 2026's Most-Watched Weight Loss Combos
The incretin therapy landscape is evolving at breakneck speed. While semaglutide and tirzepatide reshaped obesity treatment over the past few years, the next generation of multi-receptor agonists and combination therapies promises even greate